Latanoprost/Timolol Stada (Latanoprost, Timolol)

The combination contains two agents: latanoprost, a prostaglandin analog that remodels extracellular matrix to increase uveoscleral outflow of aqueous humor, and timolol, a non‑selective beta‑blocker that reduces aqueous humor production by blocking β‑adrenergic receptors in the ciliary body. Together they produce a greater pressure‑lowering effect than either component alone.

The specific dosing regimen is determined by the prescribing eye‑care professional. Typically, one drop is instilled in each affected eye once daily, but the exact frequency and duration are individualized based on the patient’s response and clinical judgment.

Safety data for Latanoprost/Timolol in pregnancy and lactation are limited. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made in consultation with a healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Latanoprost alone primarily increases aqueous outflow, while the addition of timolol also reduces aqueous production. Clinical experience shows that the combination can achieve a greater and more consistent reduction in intraocular pressure, which may be advantageous for patients who need additional pressure control beyond what a single agent provides.

Store the ophthalmic solution at room temperature, below 25 °C, in the original container. Protect it from light and moisture, and keep the bottle tightly closed when not in use. Do not freeze the product.

The medication is applied as an eye drop. The patient should wash their hands, tilt the head back, pull down the lower eyelid to form a pocket, and place one drop into the conjunctival sac. Close the eye gently for a few seconds and avoid blinking excessively. Do not touch the tip of the bottle to the eye or any surface.

Serious adverse events, although rare, include severe allergic reactions (such as swelling, rash, or breathing difficulty), persistent ocular inflammation (uveitis or keratitis), and systemic bradycardia or heart block, especially in patients with pre‑existing cardiac conditions. Any sudden vision changes, eye pain, or systemic symptoms should prompt immediate medical evaluation.

Patients with known hypersensitivity to latanoprost, timolol, or any excipients in the formulation should avoid the product. It is also contraindicated in individuals with severe bradycardia, second‑ or third‑degree heart block, uncontrolled asthma, or chronic obstructive pulmonary disease without careful medical supervision.